A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
Clinical trial NCT03235544 · COMPLETED
Trial details
- NCT number
- NCT03235544
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2024-04-30
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.